We are live on ! Find out more
MOR

MorphoSys AG American Depositary Shares

Delisted

MOR was delisted on the 2nd of August, 2024.

27 hedge funds and large institutions have $43.6M invested in MorphoSys AG American Depositary Shares in 2022 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 7 increasing their positions, 7 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

209% more capital invested

Capital invested by funds: $14.1M → $43.6M (+$29.5M)

80% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 5

17% more funds holding

Funds holding: 2327 (+4)

0% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 7

Holders
27
Holders Change
+4
Holders Change %
+17.39%
% of All Funds
0.43%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
9
Increased
7
Reduced
7
Closed
5
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
T. Rowe Price Investment Management
1
T. Rowe Price Investment Management
Maryland
$26.1M +$32.5M +7,278,098 New
Hudson Bay Capital Management
2
Hudson Bay Capital Management
Connecticut
$3.26M +$313K +70,000 +8%
LGM
3
Logos Global Management
California
$3.22M +$4.02M +900,000 New
OM
4
Opaleye Management
Massachusetts
$3.21M +$3.47M +775,585 +641%
Millennium Management
5
Millennium Management
New York
$2.95M -$581K -129,874 -14%
ABG
6
Ally Bridge Group
New York
$1.45M +$1.39M +310,571 +327%
Fidelity Investments
7
Fidelity Investments
Massachusetts
$777K +$384K +85,800 +65%
AA
8
AlphaCentric Advisors
Puerto Rico
$662K
Morgan Stanley
9
Morgan Stanley
New York
$533K -$51.9K -11,599 -7%
TD Asset Management
10
TD Asset Management
Ontario, Canada
$509K +$636K +142,268 New
TCM
11
Tekla Capital Management
Massachusetts
$293K
Optiver Holding
12
Optiver Holding
Netherlands
$223K +$208K +46,523 +293%
CS
13
Candriam SCA
Luxembourg
$208K
Goldman Sachs
14
Goldman Sachs
New York
$107K -$58 -13 -0%
BlackRock
15
BlackRock
New York
$84.9K +$38K +8,496 +56%
Susquehanna International Group
16
Susquehanna International Group
Pennsylvania
$38.4K +$48K +10,729 New
Bank of America
17
Bank of America
North Carolina
$8.32K -$35.1K -7,858 -77%
US Bancorp
18
US Bancorp
Minnesota
$8.3K +$10.2K +2,274 +5,168%
KIA
19
Kraematon Investment Advisors
Massachusetts
$7.16K +$8.94K +2,000 New
LC
20
Lindbrook Capital
California
$5.18K +$6.47K +1,448 New
S
21
SignatureFD
Georgia
$3.17K -$5.33K -1,192 -57%
UBS Group
22
UBS Group
Switzerland
$3.01K -$19.2K -4,299 -84%
Royal Bank of Canada
23
Royal Bank of Canada
Ontario, Canada
$1K
BNP Paribas Financial Markets
24
BNP Paribas Financial Markets
France
$716 +$894 +200 New
Wells Fargo
25
Wells Fargo
California
$451 -$1.97K -440 -78%

MOR Hedge Fund Activity: Q4 2022 in Review

27 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in MorphoSys AG American Depositary Shares (MOR) for Q4 2022, worth a combined $43.6M — up 209% from $14.1M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new MOR positions and 5 closed out — a net gain of 4 holders — while 7 added to existing stakes and 7 trimmed.

The largest buyer was T. Rowe Price Investment Management, opening a new position worth an estimated $32.5M. The largest seller was Millennium Management, cutting an estimated $581K.

  • 27 institutional investors held MorphoSys AG American Depositary Shares (MOR) as of Q4 2022, up from 23 in Q3 2022.
  • Funds reported $43.6M of MorphoSys AG American Depositary Shares stock for Q4 2022, up 209% quarter-over-quarter.
  • 9 funds opened new MorphoSys AG American Depositary Shares positions in Q4 2022 and 5 closed out, a net change of +4 holders.
  • The largest MorphoSys AG American Depositary Shares buyer in Q4 2022 was T. Rowe Price Investment Management, an estimated $32.5M added.
  • The largest MorphoSys AG American Depositary Shares seller in Q4 2022 was Millennium Management, an estimated $581K sold.

Based on aggregated 13F filings for Q4 2022.